Deal of the Day — limited-time pharmacy picks!
Imatib 100mg Tablet

Imatib 100mg Tablet

Prescription requiredRx Required

Salt Composition: Imatinib

Expiry Date: 01/2028

Special offer

Buy at $6.82

$6.82

Inclusive of all taxes

▼

10 Tablet(s) In A Strip ADD TO CART

About The Product

blood cancer

Description

Imatib 100mg tablet is a targeted therapy medication used in the treatment of several types of cancer such as Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GISTs). Its active ingredient is Imatinib which belongs to the Tyrosine kinase inhibitor.

It works by damaging the The medicine works by inhibiting the BCR- ABL tyrosine kinase enzyme, which is responsible for the growth of cancer cells in the body. The anti-cancer dosage and duration is only administered by the healthcare professional.

Uses

  • Chronic Myeloid Leukemia (CML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Gastrointestinal Stromal Tumors (GISTs)

Side Effects

Doctor recommend to take Imatib 100mg tablet under strict supervision as it contains common and severe side effects that are harmful to the body. Consult the doctor if any of the symptoms persist or worsen:

  • Muscle cramps and pain
  • Diarrhea
  • Skin rash, night sweats
  • Tiredness, dizziness
  • Abdominal pain
  • Increased weight
  • Decreased RBC and WBC cells
  • Headache
  • Cough, Inflammation in the nose
  • Fever, lack of sleep

  • Heart failure
  • GI disorders
  • Hypothyroidism
  • Liver failure
  • Swelling in the body

  • Swelling in the face, legs, ankles, and feet
  • Nausea, vomiting

How To Use

  • Imatib 100mg tablet should be taken at the same time every day to increase the effectiveness of the medication.
  • Proper and correct dosage should be administered by a professional healthcare professional only.
  • Do not overdose or skip the medication, as it may increase the risk of side effects.
  • Consistency is key; the medicine takes several weeks or months to show results.
  • Use it regularly as directed by the healthcare professional to get the benefit.

How It Works

Imatib 100mg tablet works by inhibiting the BCR- ABL tyrosine kinase enzyme, which is responsible for the growth of cancer cells. Blocking the enzyme, it helps stop the formation of tumor cells.

It also prevents the body from further growing cancer in the body. The active dose of the medication should be taken exactly as prescribed by the doctor.

Safety Advice

Alcohol
Taking Imatib100mg tablet with alcohol may be dangerous to the patient's health but consult the doctor before taking the medication.
Pregnancy
Imatib 100mg tablet is not recommended to pregnant and breastfeeding women as it may affect the fetus or newborn. Take guidance from a healthcare expert to ensure safety and precautions.
Breast Feeding
Breastfeeding women should not be advisable for taking Imatib 100mg tablet as the medicine is passed through breast that somehow affect breast milk. Discuss with the doctor for more query.
Driving
Imatib 100mg tablet may not cause dizziness or sleepiness but patient may still experience some side effects. It is important to monitor the response of medication and report any unusual symptoms to the doctor.
Kidney
Kidney patients should take precautions while using Imatib 100mg tablet, as dose adjustment and a doctor's prescription are much needed.
Liver
Imatib 100mg tablet is unsafe for liver patients as this may cause common as well as severe side effects. Consult the healthcare supervisor for proper medical attention.

FAQs

Imatib 100mg tablet is taken by patients who are patients of Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GISTs).

References

  • Druker, B. J. (2004). Imatinib as a paradigm of targeted therapies. Advances in cancer research, 91, 1-30. https://pubmed.ncbi.nlm.nih.gov/15327887/
  • Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., ... & Larson, R. A. (2006). Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. New England Journal of Medicine, 355(23), 2408-2417. https://pubmed.ncbi.nlm.nih.gov/17151364/
  • Shah, N. P. (2005). Loss of response to imatinib: mechanisms and management. ASH Education Program Book, 2005(1), 183-187. https://pubmed.ncbi.nlm.nih.gov/16304378/
  • Manley, P. W., Cowan-Jacob, S. W., Buchdunger, E., Fabbro, D., Fendrich, G., Furet, P., ... & Zimmermann, J. (2002). Imatinib: a selective tyrosine kinase inhibitor. European journal of cancer, 38, S19-S27. https://pubmed.ncbi.nlm.nih.gov/12528769/
  • Iqbal, N., & Iqbal, N. (2014). Imatinib: a breakthrough of targeted therapy in cancer. Chemotherapy research and practice, 2014(1), 357027. https://pubmed.ncbi.nlm.nih.gov/24963404/

Certified Content

Written By
Venika Choudhary

Venika Choudhary

Medical Content Writer @ Magicine Pharma

Reviewed By
Dr. Aditya Sarin

Dr. Aditya Sarin

MBBS, MD - General Medicine, DrNB - Medical Oncology | 11 Years Experience

Check Our Editorial Policy

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026